Skip to main content
Signal8
BEDU-ADDO FRANK profile photo

Frank Bedu-Addo

CIK: 0001770756

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PDS Biotechnology Corp logo
PDSB

PDS Biotechnology Corp

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • PDS Biotechnology Corp logo
    PDSB

    PDS Biotechnology Corp

    Jan 12, 2026
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    548.8K shares-
  • PDS Biotechnology Corp logo
    PDSB

    PDS Biotechnology Corp

    Jun 12, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    150K shares-
  • PDS Biotechnology Corp logo
    PDSB

    PDS Biotechnology Corp

    Feb 28, 2024
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    300K shares-

1-3 of 3

About BEDU-ADDO FRANK

BEDU-ADDO FRANK (SEC CIK 0001770756) files insider reports with the SEC as President/CEO of PDS Biotechnology Corp (PDSB).

Signal8 holds 2 ownership filings by BEDU-ADDO FRANK, all Form 4s, filed between Jul 25, 2025 and Mar 3, 2026. Those filings report 3 transactions, from Feb 28, 2024 to Jan 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BEDU-ADDO FRANK's filings is in PRINCETON, NJ.

Recent filings by BEDU-ADDO FRANK

  • Jan 12, 2026: Grant or award of PDSB derivative securities (Form 4, code A).
  • Jun 12, 2025: Grant or award of PDSB derivative securities (Form 4, code A).
  • Feb 28, 2024: Grant or award of PDSB derivative securities (Form 4, code A).

Other insiders filing for PDS Biotechnology Corp (PDSB)

How to read Form 4 transaction codes